Comparison of bronchodilators in acute bronchiolitis
B. Karadag, O. Ceran, E. Dursun, G. Guven, I. Ozahi, F. Karakoc, R. Hamutcu, S. Inan, E. Dagli (Istanbul, Turkey)
Source: Annual Congress 2002 - Bronchiolitis
Session: Bronchiolitis
Session type: Oral Presentation
Number: 236
Disease area: Paediatric lung diseases
Abstract The efficacy of bronchodilators remains to be still controversal in acute bronchiolitis. We investigated the effects of salbutamol and ipratropium bromide among 69 infants hospitalized for moderate to severe bronchiolitis at their first episode of wheezing. Patients were enrolled into the study between December 1998 and March 2000. Median age of the infants was 5 months (ranging 1 to 11 months). Study group was randomly assigned to nebulised salbutamol (S) (n: 24) (2.5 mg, q4h), ipratropium bromide (I) (n: 22) (0.25 mg, tid) or placebo (P) (n: 23) (2.5 cc serum saline, q4h). Oxygen saturation, clinical score (derived from respiratory rate, wheezing score, accessory muscle score and clinical condition), heart rate and physical examination were recorded at baseline, 30 minutes, 8 hours after admission and daily thereafter. All groups were similar in terms of age, duration of illness and severity of the disease. Although the baseline evaluations were similar in all groups, 30th minute clinical scores were better in S and I groups compared to P (p<0.05, p<0.05). S and A groups were also significantly better at 8th hour with lower clinical scores (5.8*1.1and 6.0*1.0 vs.7.4±]1.2, p<0.01) and higher oxygen saturation rates (95.1*4.6 and 93.5*4.1 vs. 89.6±]2.4%, p<0.01). Clinical scores, oxygen saturation and respiratory rates were significantly better in S group after 24 hours from admission compared to groups A and P (p<0.05). After 24 hours, daily evaluations were similar in all groups. In that study group, salbutamol and ipratropium were found to be more effective than placebo in the management of acute bronchiolitis.
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Karadag, O. Ceran, E. Dursun, G. Guven, I. Ozahi, F. Karakoc, R. Hamutcu, S. Inan, E. Dagli (Istanbul, Turkey). Comparison of bronchodilators in acute bronchiolitis. Eur Respir J 2002; 20: Suppl. 38, 236
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Inefficiency of montelukast in acute bronchiolitis Source: Breathe 2008; 5: 272-273 Year: 2009
Comparative effectiveness of steroids and bronchodilators for the acute care of bronchiolitis Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors Year: 2010
Comparison of treatments with nebulised salbutamol and epinephrine in acute bronchiolitis Source: Eur Respir J 2004; 24: Suppl. 48, 344s Year: 2004
Long-term outcome of infants treated for acute bronchiolitis with inhaled steroids Source: Eur Respir J 2001; 18: Suppl. 33, 169s Year: 2001
Acute viral bronchiolitis and acute asthma Source: ERS Course 2018 - Summer school of paediatric respiratory medicine Year: 2018
Acute viral bronchiolitis and acute asthma Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine Year: 2017
Combined nebulization therapy in acute asthma exacerbation Source: Eur Respir J 2001; 18: Suppl. 33, 47s Year: 2001
Acute bronchiolitis in hospitalised patients: inappropriate use of corticosteroids Source: Eur Respir J 2005; 26: Suppl. 49, 29s Year: 2005
Utility of aerosolized budesonide therapy in acute moderate exacerbations of asthma Source: Eur Respir J 2003; 22: Suppl. 45, 283s Year: 2003
Acute bronchiolitis in intants Source: Annual Congress 2009 - Diagnosis and treatment of viral respiratory infections in early childhood Year: 2009
Clinical efficacy of nebulised budesonide in acute exacerbation of COPD Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
Mechanism by which inhaled bronchodilators prevent exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013
The role of nebulised budesonide in the treatment of acute exacerbations of COPD Source: Eur Respir J 2007; 30: 399-400 Year: 2007
Role of viruses and atypical agents in COPD acute exacerbations Source: Eur Respir J 2004; 24: Suppl. 48, 408s Year: 2004
IV salbutamol as alternative treatment to intubation in RSV epidemic acute infantile bronchiolitis Source: Annual Congress 2003 - New perspectives in bronchiolitis Year: 2003
Aerosolized budesonide therapy in acute moderate exacerbations of Indian asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 343s Year: 2004
Treatment of acute asthma Source: Eur Respir Mon 2012; 56: 172-187 Year: 2012
Nebulized therapy in bronchial asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 52s Year: 2002
Inhaled corticosteroids in the treatment of acute asthma Source: Eur Respir J 2002; 20: Suppl. 38, 305s Year: 2002
Do infants with bronchiolitis get any benefit with nebulized salbutamol? Source: Annual Congress 2011 - Biological correlates and comorbidities of childhood asthma/allergy Year: 2011